Citadel Aurobindo Biotech Limited
About Citadel Aurobindo Biotech Limited
Data last updated:
Citadel Aurobindo Biotech Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 March 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2002PLC048652. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Sardar Sulakshan Singh and Mruthyunjaya Reddy Kapuluru.
Its last annual general meeting (AGM) was held on 05 September 2020, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 43 Main Road Velacherry, Chennai, Tamil Nadu, India – 600042.
As per the financials filed for FY 2019, the company reported a revenue of ₹17,164, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹1.56 Lakh and EBITDA of -₹1.73 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
As per MCA filings, the company has satisfied charges of ₹40 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Citadel Aurobindo Biotech Limited's registered office is in Chennai - 600 042., Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address43 Main Road Velacherry, Chennai, Tamil Nadu, India – 600042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Citadel Aurobindo Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Citadel Aurobindo Biotech is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
Financials of Citadel Aurobindo Biotech Limited
FY 2019 filings availableCitadel Aurobindo Biotech Limited reported revenue of ₹17,164 (down 44% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 44% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹17,164 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Citadel Aurobindo Biotech Limited, buy the company report.
Board of directors of Citadel Aurobindo Biotech Limited
Citadel Aurobindo Biotech has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sardar Sulakshan Singh | Director | 04 Dec 2006 | 19 Years 10 Months | Current |
| Mruthyunjaya Reddy Kapuluru | Director | 15 Apr 2002 | 24 Years 6 Months | Current |
| Rajiv Krishnamurthy Also directs: Citadel Fine Pharmaceuticals Private Limited | Director | 06 Feb 2007 | 19 Years 8 Months | Current |
Auditor
Citadel Aurobindo Biotech Limited is audited by S VENKATRAM & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S VENKATRAM & CO | FY 2019 | 004656S |
Shareholding
The shareholding of Citadel Aurobindo Biotech Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Citadel Aurobindo Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2003 | 90293101 | Uti Bank Limited | ₹30 Cr | Satisfied | |
| 21 Oct 2002 | 90293065 | Standard Chartered Bank | ₹10 Cr | Satisfied |
To see the full charge records of Citadel Aurobindo Biotech Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Citadel Aurobindo Biotech Limited has 8 court cases on record: 2 filed by Citadel Aurobindo Biotech, 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 4 | 0 |
| District courts | 2 | 2 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by Polaris Healthcare Private Ltd | Disposed |
| Bombay High Court | Court case (CONP) | Filed against the company by Medley Pharmaceuticals Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Medley Pharmaceuticals Limited | Disposed |
| Supreme Court | Court case (1802-Ordinary Civil Matters : T.P. Under Section 25 of the C.P.C.) | Filed by the company against Medley Pharmaceuticals Ltd. Anr. | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by an individual | Disposed |
To see the full case history of Citadel Aurobindo Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Citadel Aurobindo Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Citadel Aurobindo Biotech has 3 associated companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
GST
Citadel Aurobindo Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Citadel Aurobindo Biotech Limited, buy the company report.
Recent activity
Citadel Aurobindo Biotech Limited has 7 board changes on record since 2002: 3 appointments and 4 cessations. The latest: Sadananda Reddy Sannareddy ceased to be Director on 30 Mar 2007.
2 earlier events are in the company report.
Frequently asked questions
Citadel Aurobindo Biotech is an active public limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 March 2002 (24+ years old) and is registered under CIN U24231TN2002PLC048652.
Citadel Aurobindo Biotech has 3 current directors:
- Sardar Sulakshan Singh - Director
- Mruthyunjaya Reddy Kapuluru - Director
- Rajiv Krishnamurthy - Director
The latest financial statements of Citadel Aurobindo Biotech on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 05 September 2020. Year-wise statements from 2015 are in the company report.
No. Citadel Aurobindo Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Citadel Aurobindo Biotech is U24231TN2002PLC048652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Citadel Aurobindo Biotech has 8 court cases on record: 2 filed by the company and 6 filed against it. Most are in the high courts.
Citadel Aurobindo Biotech was incorporated on 22 March 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chennai.
Sadananda Reddy Sannareddy ceased to be Director on 30 Mar 2007. Rajiv Krishnamurthy was appointed as Director on 06 Feb 2007. Padmanoor Harihara Rao Rajendra Rao ceased to be Nominee Director on 25 Jan 2007. Citadel Aurobindo Biotech has 7 board changes on record in total.
The registered office of Citadel Aurobindo Biotech is at 43 Main Road Velacherry, Chennai, Tamil Nadu, India – 600042.
Citadel Aurobindo Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.